You are currently viewing a new version of our website. To view the old version click .
Cancers
  • Correction
  • Open Access

7 May 2025

Correction: Turchi et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038

,
,
,
,
,
,
,
,
and
1
CNRS, INSERM, Institut de Biologie Valrose, Team INSERM “Cancer Stem Cell Plasticity and Functional Intra-tumor Heterogeneity”, Université Côte D’Azur, 06107 Nice, France
2
DRCI, CHU de Nice, 06107 Nice, France
3
CNRS UMR8246, INSERM U1130, Neuroscience Paris Seine-IBPS Laboratory, Team Glial Plasticity and NeuroOncology, Sorbonne Université, 75252 Paris, France
4
Stemness in Gliomas Laboratory, Cancer Initiation and Tumoral Cell Identity (CITI) Department, INSERM 1052, CNRS 5286, Centre Léon Bérard, 69008 Lyon, France
This article belongs to the Special Issue Brain Cancer Stem Cells in Children and Adults
In the original publication [], errors were made in Figure 2. Panels 2A,C,E are incorrect and do not correspond to the original blot. The correct panels, in Figure 2, and caption are shown below. The authors apologize for any inconvenience caused and state that the scientific conclusions are not affected. This correction has been approved by the Academic Editor. The original publication has also been updated.
Figure 2. CELF2 expression and regulation in patient-derived GSCs. (A) Western blot analysis showing CELF2 expression in proliferating GSCs and their serum-differentiated counterparts (three days of differentiation). (B) Western blot showing CELF2 expression during the time course of GSC differentiation in serum medium. (C) GB5, TG6 and GB1 have been transfected by a synthetic miR-199a-3p or by a control non-relevant miRNA. CELF2 expression is revealed in both condition by western blot. (D) Immunofluorescence showing the expression of CELF2 or Nestin (marker of GSCs) in GB5 stably expressing a synthetic miR-199a-3p or a control non-relevant sequence. Scale = 100 µM. Histogram on the right displays the quantification of the number of positive cells (p value < 0.0001 ****). (E) GB5, TG6 and GB1 have been transfected by an anti-miR-199a-3p (synthetic sequence) or by a non-relevant sequence as anti-miRNA control. CELF2 expression is revealed by western blot.

Reference

  1. Turchi, L.; Sakakini, N.; Saviane, G.; Polo, B.; Saurty-Seerunghen, M.S.; Gabut, M.; Gouillou, C.A.; Guerlais, V.; Pasquier, C.; Vignais, M.L.; et al. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. Cancers 2023, 15, 5038. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.